-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology Brain In Situ Model
Author:
InnoModels
Release time:
2024-09-02
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. with its leading brain in-situ modeling technology, like a bright star, is gradually illuminating the future of the field of neuroscience. This technology not only provides scientists with a more realistic and complex research platform, but also greatly advances our understanding of brain function and disease mechanisms.
InnoModels Biotechnology and Brain In Situ Modeling Technology
Founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and the Institute of Immunology of Shanghai Jiaotong University, InnoModels Biotechnology (Beijing) Co., Ltd. has been committed to promoting innovation in biomedical research since its inception. As one of its core technologies, brain in situ modeling is becoming a new favorite in the field of neuroscience research.
Brain in-situ modeling is a technology that transplants human or animal brain tissue cells into an in vitro environment in a laboratory and maintains their structure and function in situ. At the core of this technology is the use of state-of-the-art cell culture and tissue engineering methods that allow researchers to conduct neuroscience experiments in a more natural environment. By restoring the in-situ structure of brain tissue, including neuronal connections and distribution, researchers are able to better simulate and understand the complex functions of the brain.

Technical Advantages and Application Prospects
InnoModels' in situ brain modeling technology has significant advantages. First, it is capable of highly restoring the in situ structure of brain tissue, providing unprecedented realism and complexity for neuroscience research. This realism enables researchers to more accurately simulate the various physiological and pathological states of the brain, thus enabling in-depth exploration of brain function and disease mechanisms.
Second, brain in situ modeling technology can be used to model a variety of neurological diseases, such as Alzheimer's disease and Parkinson's disease. The establishment of these disease models provides scientists with a powerful tool to study disease mechanisms and is expected to accelerate therapeutic research on related diseases. At the same time, these models can also be used as a platform for drug testing, allowing researchers to assess the effects of new drugs on brain function and provide more accurate predictions for drug development.
In addition, brain in situ modeling technology shows great potential in simulating the growth and treatment response of brain tumors. By simulating the growth environment and treatment process of tumors, researchers can obtain key data to provide strong support for the evaluation of central nervous system drugs. The application of this technology not only helps to promote the development of tumor treatment strategies, but also provides a scientific basis for the development of individualized medical plans.
Looking to the future
As brain in situ modeling technology continues to evolve, InnoModels Biotechnology will continue to drive innovation in this field. In the future, we expect to see the creation of more disease models, as well as more accurate drug testing and customized treatment plans. This technology is expected to revolutionize the field of neuroscience, and thus move the research and treatment of neurological diseases forward.
At the same time, InnoModels Biotechnology will also explore and innovate in other areas of in situ modeling technology, such as simulating the growth and therapeutic response of tumors in other organs. The development and application of these technologies will further expand the boundaries of biomedical research and provide new ideas and possibilities for the treatment and prevention of more diseases.
In conclusion, the brain in-situ modeling technology of InnoModels Biotechnology represents the forefront of neuroscience research. The application of this technology will help us understand the structure and function of the brain in a more comprehensive and in-depth manner, and open up new paths for the treatment and prevention of neurological diseases. As this field continues to develop, we are excited about the future prospects of neuroscience research.
Previous Page
Previous Page
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd